Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspart insulin 50 injection vs NovoMix 50 in type 2 diabetes
CTR20160331Phase 3Completed
- Sponsor
- Tonghua Dongbao
- Start
- Dec 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of insulin aspart in type 2 diabetes mellitus (T2DM), sponsored by Tonghua Dongbao. Started Dec 2017; status: completed.
02
Drugs
insulin aspart
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20160331.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160331.